The global ependymoma market is anticipated to grow at a significant CAGR of 4.7% during the forecast period. The rising prevalence of brain tumor and cancer cases is the major factor driving the growth of the market. According to the American Society of Clinical Oncology (ASCO), ependymoma occurs most often in young children, accounting for […]
Tag Archives: Ependymoma Drug Market
The global ependymoma drug market is anticipated to grow at a considerable CAGR of 4.7% during the forecast period. One of the major factors that are driving the market for ependymoma drugs includes the rising prevalence of neurofibromatosis type 2 (NF2) disorder, which increases the risk of progression of spinal ependymomas. In addition, the extensive financial support […]